Evidence map›Paper›PMID 40531536›Full record

ArticleJAMA network open2025

Engagement in the National Diabetes Prevention Program Among Hispanic Men.

Christopher J Gonzalez, Clarence N Perez-Mejia, Noelia Hernandez, Hana Flaxman, Cara Stephenson-Hunter, Eric Gil, Elaine De Leon, Taynara Formagini, Earle C Chambers, Martin F Shapiro and 1 more

Abstract read
In one paragraph

Article in JAMA network open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Christopher J GonzalezDivision of General Internal Medicine, Weill Cornell Medical College, New York, New York.
Clarence N Perez-MejiaDivision of General Internal Medicine, Weill Cornell Medical College, New York, New York.
Noelia HernandezDivision of General Internal Medicine, Weill Cornell Medical College, New York, New York.
Hana FlaxmanMD Program, Weill Cornell Medicine, New York, New York.
Cara Stephenson-HunterHarold and Muriel Block Institute for Clinical and Translational Research, Albert Einstein College of Medicine, Bronx, New York.
Eric GilDepartment of Family and Social Medicine, Albert Einstein College of Medicine, Bronx, New York.
Elaine De LeonDepartment of Medicine, New York University Grossman School of Medicine, New York.
Taynara FormaginiDepartment of Family Medicine, University of California, San Diego.
Earle C ChambersDepartment of Family and Social Medicine, Albert Einstein College of Medicine, Bronx, New York.
Martin F ShapiroDivision of General Internal Medicine, Weill Cornell Medical College, New York, New York.
Jeffrey S GonzalezDepartment of Medicine, Albert Einstein College of Medicine, Bronx, New York.

Funding

Einstein-Montefiore Clinical and Translational Science Award HubUM1TR004400 · NCATS · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI Jessica Kahn, Mimi Y Kim · 2023 to 2026
$17.3M
New York Regional Center for Diabetes Translation Research - Translational Intervention Methodology CoreP30DK111022 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI JEFFREY GONZALEZ · 2016 to 2026
$7.8M
UCSD Integrated Cardiovascular Epidemiology FellowshipT32HL079891 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Matthew A Allison · 2007 to 2026
$6.7M
UCSF Research in Implementation Sciences for Equity (RISE)R25HL126146 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CRYSTAL WILEY CENE, Alicia Fernandez · 2014 to 2026
$4.6M
Power-Up Study Administrative Supplement to Promote DiversityR01DK121896 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI CHAMBERS, EARLE C, GONZALEZ, JEFFREY S · 2019 to 2023
$3.6M
CTSA K12 Program at Einstein-MontefioreK12TR004411 · NCATS · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI Deepa Rastogi · 2023 to 2026
$3.0M
Developing and Piloting FUERTE: Federally qUalified health centers Engaging Hispanic men at Risk of DiabeTEsK23DK139410 · NIDDK · WEILL MEDICAL COLL OF CORNELL UNIV · PI Christopher Jesus Gonzalez · 2025 to 2026
$340k
NCATS NIH HHS K12 TR004411NCATS NIH HHS UM1 TR004400NHLBI NIH HHS R25 HL126146NHLBI NIH HHS T32 HL079891NIDDK NIH HHS K23 DK139410NIDDK NIH HHS P30 DK111022NIDDK NIH HHS R01 DK121896
6 · The paper itself

Abstract

Importance: Hispanic men experience higher rates of diabetes compared with non-Hispanic White men but remain underrepresented in preventive lifestyle interventions. Objective: To identify unique reasons for Hispanic men's low engagement in the National Diabetes Prevention Program (NDPP) compared with those with high engagement to inform strategies for improving participation. Design, Setting, and Participants: This qualitative study recruited Hispanic men aged 18 years and older and at risk for diabetes per electronic medical records from June 2023 to February 2024 from primary care sites affiliated with hospital-associated Montefiore Health Systems related to an ongoing clinical trial called Power Up. Patients were invited to participate in one-time phone interviews. Interviews were analyzed deductively, guided by behavior change frameworks. Exposure: Participant's level of engagement varied with representation balanced between those demonstrating low and high engagement in the NDPP (attendance at <4 and ≥4 sessions, respectively). Main Outcomes and Measures: Planned study outcomes included NDPP notable factors associated with low engagement. Results: Of 32 Hispanic men who completed interviews (20 patients [62.5%]aged >50 years), 15 had low engagement in the NDPP, 13 (87%) were not born in the US, 12 (80%) had limited English proficiency, and 8 (53%) did not complete high school. Three major themes and 11 subthemes emerged. Hispanic men with low engagement discussed limited awareness of their prediabetes diagnosis, lifestyle change self-sufficiency, and skepticism about their diabetes risk and the benefits of NDPP. Also mentioned were financial barriers, restricted access to the program, and the perceived negatives of participation outweighing potential benefits. Conclusions and Relevance: Addressing the unique barriers faced by Hispanic men in engaging with the NDPP is critical to reducing diabetes-related inequities and may require tackling knowledge gaps, financial barriers, and perceptions of program relevance before, during, and after enrollment. Future research should explore how to tailor recruitment strategies and program content to Hispanic men's specific identities, motivations, and challenges.

Indexed as

Diabetes MellitusDiabetes Mellitus, Type 2Hispanic or LatinoPatient ParticipationAdultAgedHumansMaleMiddle AgedQualitative ResearchUnited States

Identifiers

PMID40531536
PMCPMC12177656

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.